Tony Ho
Director/Board Member at ITEOS THERAPEUTICS, INC.
Net worth: - $ as of 2024-03-30
Profile
Dr. Tony W. Ho is an Independent Director at iTeos Therapeutics, Inc., an Independent Director at Engrail Therapeutics, Inc., an Executive VP, Head-Research & Development at CRISPR Therapeutics AG, an Adjunct Associate Professor at University of Pennsylvania and an Assistant Professor-Neurology at The Johns Hopkins University. He is on the Board of Directors at iTeos Therapeutics, Inc. and Engrail Therapeutics, Inc. Dr. Ho was previously employed as a Senior Vice President & Head-Oncology by Astrazeneca AG, a Chief Scientific Officer by Neuronyx, Inc., a Head-Merck Research Laboratories by Merck & Co., Inc., a Head-Neurology & Ophthalmology by Merck Research Laboratories Massachusetts LLC, and an Assistant Professor by The Johns Hopkins Hospital, Inc. He received his undergraduate degree from the University of California, Los Angeles and a doctorate degree from The Johns Hopkins University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ITEOS THERAPEUTICS, INC.
-.--% | 2023-06-12 | 0 ( -.--% ) | - $ | 2024-03-30 |
Latest news about Tony Ho
Tony Ho active positions
| Companies | Position | Start |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Director/Board Member | 2021-05-02 |
| The Johns Hopkins University | Corporate Officer/Principal | - |
| University of Pennsylvania | Corporate Officer/Principal | - |
Engrail Therapeutics, Inc.
 Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA. | Director/Board Member | 2020-07-28 |
Hangzhou Qihan Biotech Co., Ltd.
 Hangzhou Qihan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Hangzhou Qihan Biotech Co., Ltd. is a biotech company that applies genome-editing technology to develop novel cell therapies and organs for transplantation. The company is based in Hangzhou, China. The Chinese company's mission is to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other complex medical conditions. Qihan Biotech has raised two rounds of financing and is advancing its cell therapy programs into IND enabling investigations. It was founded in 2017 by Luhan Yang and George McDonald Church, with Luhan Yang serving as the CEO since then. | Director/Board Member | 2022-10-16 |
| Pivotal Bioventure Partners China Advisor (Beijing) Co. Ltd. | Corporate Officer/Principal | - |
Pivotal Bioventure Partners Investment Advisor LLC
 Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | Corporate Officer/Principal | 2022-02-28 |
Former positions of Tony Ho
| Companies | Position | End |
|---|---|---|
| CRISPR THERAPEUTICS AG | Chief Tech/Sci/R&D Officer | 2021-12-13 |
| Astrazeneca AG | Corporate Officer/Principal | 2017-06-30 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Tony Ho
| University of California, Los Angeles | Undergraduate Degree |
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| CRISPR THERAPEUTICS AG | Health Technology |
| ITEOS THERAPEUTICS, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Neuronyx, Inc.
 Neuronyx, Inc. Medical SpecialtiesHealth Technology Neuronyx, Inc. develops and distributes bone marrow derived stem cells. It also develops cellular therapies focusing on ischemic diseases to repair damaged cardiac tissues in patients suffering from heart attack. The company was founded by Hubert J.P. Schoemaker in 1999 and is located in Malvern, PA. | Health Technology |
The Johns Hopkins Hospital, Inc.
 The Johns Hopkins Hospital, Inc. Hospital/Nursing ManagementHealth Services The Johns Hopkins Hospital, Inc. provides healthcare services. The hospital is affiliated to the Johns Hopkins University School of Medicine. It offers inpatient and outpatient health services that include general medicine, emergency and trauma care, pediatrics, maternity, and senior care. The company was founded in 1889 and is headquartered in Baltimore, MD. | Health Services |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
| Astrazeneca AG | |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | Finance |
| Pivotal Bioventure Partners China Advisor (Beijing) Co. Ltd. | Finance |
Hangzhou Qihan Biotech Co., Ltd.
Hangzhou Qihan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Hangzhou Qihan Biotech Co., Ltd. is a biotech company that applies genome-editing technology to develop novel cell therapies and organs for transplantation. The company is based in Hangzhou, China. The Chinese company's mission is to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other complex medical conditions. Qihan Biotech has raised two rounds of financing and is advancing its cell therapy programs into IND enabling investigations. It was founded in 2017 by Luhan Yang and George McDonald Church, with Luhan Yang serving as the CEO since then. | Health Services |
Engrail Therapeutics, Inc.
Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Tony Ho
